Latest Intelligence on Pain

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
Expert View
Expert View

Making the most of new indications

Published By Datamonitor
29 Sep 2000
CommentWire
CommentWire

Cephalon/Anesta: painful times could be ahead

Published By Datamonitor
12 Oct 2000
CommentWire
CommentWire

Vernalis: benefiting from SB's regulatory headaches

Published By Datamonitor
14 Dec 2000
CommentWire
CommentWire

Adolor: no pain, large gains

Published By Datamonitor
21 Dec 2000
CommentWire
CommentWire

Genzyme BioSurgery: the WSJ was wrong, they cry

Published By Datamonitor
26 Jan 2001
CommentWire
CommentWire

Pfizer: could pregabalin hype be premature?

Published By Datamonitor
14 Feb 2001
ResearchWire
ResearchWire

Migraines: sales of triptans to double by 2007

Published By Datamonitor
12 Mar 2001
ResearchWire
ResearchWire

Pain: on the increase

Published By Datamonitor
19 Mar 2001
ResearchWire
ResearchWire

Pain relief: opioids catching NSAIDs

Published By Datamonitor
22 Mar 2001
CommentWire
CommentWire

Durect: DUROS to cut the pain

Published By Datamonitor
15 May 2001

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.